A controversial Alzheimer’s drug has already yielded $2 million in sales.


By BY REBECCA ROBBINS from NYT Business https://ift.tt/3BumtvX

Comments

Popular posts from this blog

West Virginia state senator charged with prostitution

North Korea vs. the F-35 Stealth Fighter (Who Wins? Who Dies?)